A Phase 3, multicenter, open label, randomized, non-comparative two-arm study of ivosidenib (IVO) monotherapy and azacitidine (AZA) monotherapy in adult patients with hypomethylating agent (HMA) naive myelodysplastic syndromes (MDS) with an isocitrate dehydrogenase-1 (IDH1) mutation (PyramIDH study)

GO TO STUDY

A Phase 3, randomized, double-blind, study evaluating efficacy and safety of riliprubart versus intravenous immunoglobulin (IVIg) in participants with chronic inflammatory demyelinating polyneuropathy (VITALIZE)

GO TO STUDY

Non-Invasive Testing of blood biomarkers in pregnAnt women (NITA)

GO TO STUDY

Oxford Musculoskeletal Biobank RENEWAL

GO TO STUDY

Natural History studies of participants with primary and secondary headache and facial pain disorders

GO TO STUDY

Human brain mechanisms underlying motivation and apathy

GO TO STUDY

Investigating the effects of beta transcranial stimulation to advance stroke rehabilitation (T-STAR)

GO TO STUDY

Oxford Luteal Dysfunction and Placental Insufficiency Study (OxLuPIn)

GO TO STUDY

INTEGRATOR Research Tissue Bank

GO TO STUDY

Cancer and neoplasms

A prospective randomized, double-blind, placebo-controlled, multi-center phase IIb study to evaluate the efficacy and safety of mocravimod in acute myeloid leukemia (AML) patients undergoing allogeneic hematopoietic stem cell transplant (HSCT) (MO-TRANS (PKRPCOO1))

GO TO STUDY